Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 1360622-01-0
2. Gs-248
3. Fn57bdr4da
4. 1h-benzimidazole-5-carboxamide, 2-((2,6-dichloro-3-(((2,2-dimethyl-1-oxopropyl)amino)methyl)phenyl)amino)-6-(2,2-difluoroethoxy)-1-methyl-n-(trans-4-(trifluoromethyl)cyclohexyl)-
5. 2-((2,6-dichloro-3-(((2,2-dimethyl-1-oxopropyl)amino)methyl)phenyl)amino)-6-(2,2-difluoroethoxy)-1-methyl-n-(trans-4-(trifluoromethyl)cyclohexyl)-1h-benzimidazole-5-carboxamide
6. Vipoglanstat [inn]
7. Unii-fn57bdr4da
8. Bi-1029539
9. Orb1738606
10. Chembl3694493
11. Schembl10169877
12. Schembl11970119
13. Schembl29589517
14. Schembl30789348
15. Gtpl12209
16. Pforuffggnolpj-qaqduykdsa-n
17. Bdbm124265
18. Gs248
19. Da-78897
20. Ms-31082
21. Bi1029539
22. Hy-147416
23. Bi 1029539
24. Cs-0564159
25. Us8759537, 1
26. 2-((2,6-dichloro-3-(pivalamidomethyl)phenyl)amino)-6-(2,2-difluoroethoxy)-1-methyl-n-(trans-4-(trifluoromethyl)cyclohexyl)-1h-benzo[d]imidazole-5-carboxamide
27. 2-[2,6-dichloro-3-[(2,2-dimethylpropanoylamino)methyl]anilino]-6-(2,2-difluoroethoxy)-1-methyl-n-[4-(trifluoromethyl)cyclohexyl]benzimidazole-5-carboxamide
28. 2-{2,6-dichloro-3-[(2,2-dimethylpropanamido)methyl]anilino}-6-(2,2-difluoroethoxy)-1-methyl-n-[trans-4-(trifluoromethyl)cyclohexyl]-1h-benzimidazole-5-carboxamide
| Molecular Weight | 678.5 g/mol |
|---|---|
| Molecular Formula | C30H34Cl2F5N5O3 |
| XLogP3 | 7.8 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 10 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 97.3 |
| Heavy Atom Count | 45 |
| Formal Charge | 0 |
| Complexity | 1010 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
27
PharmaCompass offers a list of Vipoglanstat API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Vipoglanstat manufacturer or Vipoglanstat supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Vipoglanstat manufacturer or Vipoglanstat supplier.
A Vipoglanstat manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Vipoglanstat, including repackagers and relabelers. The FDA regulates Vipoglanstat manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Vipoglanstat API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Vipoglanstat supplier is an individual or a company that provides Vipoglanstat active pharmaceutical ingredient (API) or Vipoglanstat finished formulations upon request. The Vipoglanstat suppliers may include Vipoglanstat API manufacturers, exporters, distributors and traders.
Vipoglanstat Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Vipoglanstat GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Vipoglanstat GMP manufacturer or Vipoglanstat GMP API supplier for your needs.
A Vipoglanstat CoA (Certificate of Analysis) is a formal document that attests to Vipoglanstat's compliance with Vipoglanstat specifications and serves as a tool for batch-level quality control.
Vipoglanstat CoA mostly includes findings from lab analyses of a specific batch. For each Vipoglanstat CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Vipoglanstat may be tested according to a variety of international standards, such as European Pharmacopoeia (Vipoglanstat EP), Vipoglanstat JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Vipoglanstat USP).
